| Trial ID: | L0544 |
| Source ID: | NCT04959578
|
| Associated Drug: |
Recombinant Human Erythropoietin
|
| Title: |
Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia of Chronic Kidney Disease
|
| Interventions: |
DRUG: Recombinant human erythropoietin|DRUG: Darbepoetin Alfa
|
| Outcome Measures: |
Primary: Mean change in hemoglobin (Hb) between baseline and the evaluation period, Hb in mg/dL, 24 -28 week | Secondary: Incidence of treatment-related adverse events in both groups during study period, 0-28 week
|
| Sponsor/Collaborators: |
Sponsor: Rufaida Mazahir
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-02-01
|
| Completion Date: |
2019-01-31
|
| Results First Posted: |
|
| Last Update Posted: |
2021-07-13
|
| Locations: |
Sir Ganga Ram Hospital, New Delhi, Delhi, 110060, India
|
| URL: |
https://clinicaltrials.gov/show/NCT04959578
|
